サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1765279

解凍システムの世界市場

Thawing Systems

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
解凍システムの世界市場
出版日: 2025年07月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

解凍システムの世界市場は2030年までに5億6,450万米ドルに達する見込み

2024年に2億9,710万米ドルと推定される解凍システムの世界市場は、分析期間2024～2030年にCAGR 11.3％で成長し、2030年には5億6,450万米ドルに達すると予測されます。本レポートで分析されているセグメントの1つである血液は、CAGR 10.1％を記録し、分析期間終了時には2億8,770万米ドルに達すると予想されています。胚セグメントの成長率は、分析期間中CAGR13.2％と推定されます。

米国市場は8,070万米ドルと推定、中国はCAGR 10.4％で成長すると予測

米国の解凍システム市場は、2024年には8,070万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに8,570万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.9％と9.5％と予測されています。欧州では、ドイツがCAGR約8.0%で成長すると予測されています。

世界の解凍システム市場- 主要動向と促進要因のまとめ

なぜ解凍システムはバイオ医薬品業界で注目を集めているのか？

解凍システムは、血漿、血液、ワクチン、組織などの生物学的サンプルの制御解凍において極めて重要な役割を果たすため、バイオ医薬品およびヘルスケア分野で不可欠なものとなっています。これらのシステムは、デリケートな生物学的製剤がその品質と有効性を損なうことなく解凍されることを保証します。生物製剤や細胞ベースの治療法の台頭により、高度で精密な自動解凍技術へのニーズが著しく高まっています。近年では、一貫した解凍プロセスを保証するリアルタイムモニタリングを提供するプログラマブルな解凍システムを採用する傾向が高まっています。このような需要の急増は、細胞治療市場の拡大や、特に臨床試験や研究環境において生物製剤のコールドチェーンの完全性を維持することが重視されるようになってきたことも背景にあります。

さまざまなセグメントと最終用途市場は、解凍システムをどのように形成しているか？

解凍システム市場は、手動式、自動式、卓上式などの製品タイプに分類され、用途や使用規模に対応しています。例えば、自動化解凍システムは、サンプルの大規模解凍に使用されるバイオ医薬品製造や研究室での採用が増加しています。エンドユーザーセグメントは、主に病院、診断研究所、バイオテクノロジー企業、研究機関で構成されています。病院分野では、輸血用の血液や血漿の製剤に解凍システムが不可欠であり、研究機関では、凍結細胞や組織の処理にこれらのシステムが不可欠です。さらに、不妊治療クリニックや臍帯血バンクでの解凍システムの使用拡大も市場拡大に貢献しています。

解凍システム市場を変革する新たな動向とは？

解凍システム市場における最近の技術革新は、効率、精度、自動化の向上に重点を置いています。例えば、カスタマイズされた解凍プロトコルのためのプログラム可能な機能を提供しながら、幅広いサンプル量に対応できるシステムを開発する傾向が高まっています。高度なセンサーとデータ管理ソリューションの統合が進むにつれて、これらのシステムは、特に生物製剤の保管と取り扱いにおいて、規制基準の遵守を保証するための重要なツールへと変化しています。もう一つの注目すべき動向は、汚染リスクを最小限に抑え、操作の利便性を高める使い捨て解凍バッグの使用が増加していることです。さらに、個別化医療や先進的な細胞治療の需要が高まり続ける中、解凍システムはこれらの成長分野の複雑なニーズに応えるべく進化しています。

解凍システム市場の成長を促進する要因は？

解凍システム市場の成長は、バイオ医薬品に対する需要の高まり、高度な治療を必要とする慢性疾患の有病率の増加、生物製剤製造部門の拡大など、いくつかの要因によって牽引されています。バイオ医薬品企業が細胞治療や遺伝子治療の研究開発に多額の投資を行っているため、正確な解凍ソリューションが急務となっています。さらに、規制当局が生物学的マテリアルの取り扱いについてより高い基準を設定しつつあり、これが準拠解凍技術への需要に拍車をかけています。特に大規模なワクチン流通に伴い、コールドチェーンの完全性を維持することが重視されるようになっていることも、市場の成長に寄与しています。最後に、運用コストを削減し生産性を向上させる自動化されたエネルギー効率の高い解凍システムの開発が、市場の拡大をさらに後押ししています。

セグメント

サンプルタイプ（血液、胚、卵子、精液）、エンドユーザー（血液銀行、病院、組織銀行、製薬・バイオテクノロジー企業、その他のエンドユーザー）

調査対象企業の例

  • Barkey GmbH & Co. KG
  • Biocision, LLC
  • Boekel Scientific, Inc.
  • Cardinal Health, Inc.
  • CytoTherm
  • GE Healthcare
  • Helmer Scientific
  • Sarstedt AG & Co.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP15187

Global Thawing Systems Market to Reach US$564.5 Million by 2030

The global market for Thawing Systems estimated at US$297.1 Million in the year 2024, is expected to reach US$564.5 Million by 2030, growing at a CAGR of 11.3% over the analysis period 2024-2030. Blood, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$287.7 Million by the end of the analysis period. Growth in the Embryo segment is estimated at 13.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$80.7 Million While China is Forecast to Grow at 10.4% CAGR

The Thawing Systems market in the U.S. is estimated at US$80.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$85.7 Million by the year 2030 trailing a CAGR of 10.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.9% and 9.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.

Global Thawing Systems Market - Key Trends and Drivers Summarized

Why Are Thawing Systems Gaining Traction in the Biopharmaceutical Industry?

Thawing systems have become essential in the biopharmaceutical and healthcare sectors due to their pivotal role in the controlled thawing of biological samples such as plasma, blood, vaccines, and tissues. These systems ensure that sensitive biological products are thawed without compromising their quality and efficacy. With the rise of biologics and cell-based therapies, the need for advanced, precise, and automated thawing technologies has grown significantly. In recent years, there has been an increasing trend toward the adoption of programmable thawing systems that offer real-time monitoring, ensuring consistent thawing processes. This surge in demand is also driven by the expanding cell therapy market and the growing emphasis on maintaining cold chain integrity for biologics, especially in clinical trials and research settings.

How Are Different Segments and End-Use Markets Shaping Thawing Systems?

The market for thawing systems is categorized by product types such as manual, automated, and benchtop systems, which cater to different applications and scales of use. Automated thawing systems, for instance, have seen increased adoption in biopharmaceutical manufacturing and research laboratories, where they are used for the large-scale thawing of samples. The end-user segments are primarily composed of hospitals, diagnostic laboratories, biotechnology firms, and research institutions. In the hospital segment, thawing systems are crucial for preparing blood and plasma for transfusions, while in research labs, these systems are essential for processing frozen cells and tissues. Additionally, the growing use of thawing systems in fertility clinics and cord blood banks is also contributing to the market’s expansion.

What Emerging Trends Are Transforming the Thawing Systems Market?

Recent innovations in the thawing systems market have focused on improving efficiency, precision, and automation. For instance, there is a rising trend toward developing systems that can handle a broad range of sample volumes while offering programmable features for customized thawing protocols. The growing integration of advanced sensors and data management solutions has transformed these systems into critical tools for ensuring compliance with regulatory standards, particularly in the storage and handling of biologics. Another notable trend is the increased use of single-use thawing bags that minimize contamination risks and offer greater operational convenience. Furthermore, as demand for personalized medicine and advanced cell therapies continues to rise, thawing systems are evolving to meet the complex needs of these growing fields.

What Factors Are Driving the Growth of the Thawing Systems Market?

The growth in the thawing systems market is driven by several factors, including the rising demand for biopharmaceuticals, the increasing prevalence of chronic diseases requiring advanced therapies, and the expansion of the biologics manufacturing sector. With biopharmaceutical companies investing heavily in research and development for cell and gene therapies, there is a pressing need for precise thawing solutions. Moreover, regulatory agencies are setting higher standards for the handling of biological materials, which is fueling the demand for compliant thawing technologies. The growing emphasis on maintaining cold chain integrity, particularly in the wake of large-scale vaccine distribution efforts, is also contributing to market growth. Finally, the development of automated and energy-efficient thawing systems, which reduce operational costs and enhance productivity, is further driving the market’s expansion.

SCOPE OF STUDY:

The report analyzes the Thawing Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Sample Type (Blood, Embryo, Ovum, Semen); End-Use (Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Barkey GmbH & Co. KG
  • Biocision, LLC
  • Boekel Scientific, Inc.
  • Cardinal Health, Inc.
  • CytoTherm
  • GE Healthcare
  • Helmer Scientific
  • Sarstedt AG & Co.
  • Sartorius AG
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Thawing Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Automated Thawing Technologies Propel Growth of Thawing Systems Market
    • Rising Adoption of Biopharmaceuticals Spurs Demand for Efficient Thawing Solutions
    • Increased Focus on Cold Chain Logistics Expands Addressable Market Opportunity
    • Growing Investment in Cell and Gene Therapy Strengthens Business Case for Thawing Systems
    • Emergence of Rapid Thawing Techniques Accelerates Demand for Innovative Thawing Systems
    • Rising Focus on Sample Integrity in Clinical Labs Spurs Need for Advanced Thawing Solutions
    • Increased Utilization of Frozen Stem Cells and Tissues Propels Market for Thawing Systems
    • Technological Innovations in Cryopreservation Fuel Market Growth for Efficient Thawing
    • Growing Number of Biobanks and Biorepositories Expands Demand for Automated Thawing Systems
    • Increasing Emphasis on Sustainability Spurs Development of Energy-efficient Thawing Systems
    • Growing Adoption of Single-use Technologies in Bioprocessing Accelerates Thawing Systems Market
    • Expansion of Biopharmaceutical Manufacturing Capabilities Boosts Demand for Thawing Equipment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Thawing Systems Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Thawing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Thawing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Embryo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Embryo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ovum by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Ovum by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Semen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Semen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Tissue Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Tissue Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: China 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Thawing Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Thawing Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • FRANCE
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: France 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 46: France Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: France 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Germany 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Germany 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Italy 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 54: Italy Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Italy 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: UK 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 58: UK Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: UK 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Rest of Europe 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Thawing Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 66: Asia-Pacific Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Asia-Pacific 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Thawing Systems by Sample Type - Blood, Embryo, Ovum and Semen - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of World 6-Year Perspective for Thawing Systems by Sample Type - Percentage Breakdown of Value Sales for Blood, Embryo, Ovum and Semen for the Years 2025 & 2030
    • TABLE 70: Rest of World Recent Past, Current & Future Analysis for Thawing Systems by End-Use - Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Rest of World 6-Year Perspective for Thawing Systems by End-Use - Percentage Breakdown of Value Sales for Blood Banks, Hospitals, Tissue Banks, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION